DrugPatentWatch Database Preview
Elite Labs Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for ELITE LABS INC, and what generic and branded alternatives to ELITE LABS INC drugs are available?
ELITE LABS INC has thirteen approved drugs.
Summary for Elite Labs Inc
| US Patents: | 0 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 13 |
Drugs and US Patents for Elite Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Labs Inc | ISRADIPINE | isradipine | CAPSULE;ORAL | 077169-002 | Apr 24, 2006 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Elite Labs Inc | DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076686-002 | Oct 24, 2005 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Elite Labs Inc | ACETAMINOPHEN AND CODEINE PHOSPHATE | acetaminophen; codeine phosphate | TABLET;ORAL | 212418-002 | Sep 10, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
